← Leaderboards
Steven M Firestine
Duquesne University
$3,051,839
Attributed
$5,217,556
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $692.2K · FY2008–19$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,217,556 · 4
By mechanism
R01$4,533,666 · 2
R21$467,530 · 1
R15$216,360 · 1
Top collaborators
- Ernesto V Abel-Santos5 shared
- Nigel Peter Minton5 shared
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadBaseGrantDesignInfectionStructureAnimal ModelCommunicable DiseasesReportingBinding (Molecular Function)Pathway InteractionsPositioning AttributePharmacophorePharmaceutical PreparationsPublic Health RelevanceInnovationLaboratoriesComputer SimulationDrug DevelopmentBiochemicalComplexInhibitor/AntagonistFoundationsStructure-Activity Relationship
Grant awards (13)
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2019 · AI
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2018 · AI
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2017 · AI
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2016 · AI
Prophylaxis of Clostridium difficile infection$692,240
R01 · FY2015 · AI
Enzymology of N5-CAIR Synthetase$312,404
R01 · FY2012 · GM · contact PI
Enzymology of N5-CAIR Synthetase$312,404
R01 · FY2011 · GM · contact PI
Enzymology of N5-CAIR Synthetase$317,753
R01 · FY2010 · GM · contact PI
Enzymology of N5-CAIR Synthetase$342,529
R01 · FY2009 · GM · contact PI
Inhibitors of polymerase/processivity factor interaction as anti-CMV agents$182,065
R21 · FY2009 · AI · contact PI
Inhibitors of polymerase/processivity factor interaction as anti-CMV agents$64,765
R21 · FY2009 · AI · contact PI
Inhibitors of polymerase/processivity factor interaction as anti-CMV agents$220,700
R21 · FY2008 · AI · contact PI
Synthesis and testing of DNA bending agents$216,360
R15 · FY2004 · GM